Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionMCF Advisors LLC
Latest Disclosed Ownership11,665 shares
Latest Disclosed Value $ 4,104,158
MCF Advisors LLC reports 11.43% increase in ownership of AMGN / Amgen Inc.

On May 11, 2026 - MCF Advisors LLC filed a 13F-HR form disclosing ownership of 11,665 shares of Amgen Inc. (MX:AMGN) valued at $4,104,158 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 10,468 shares of Amgen Inc.. This represents a change in shares of 11.43% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F AMGEN COM 031162100 11,665 1,197 11.43 4,104 19.79 0.1798
2026-02-11 2025-12-31 13F AMGEN COM 031162100 10,468 3,424 48.61 3,426 72.42 0.1893
2025-11-05 2025-09-30 13F AMGEN COM 031162100 7,044 1,671 31.10 1,988 32.47 0.1218
2025-07-15 2025-06-30 13F AMGEN COM 031162100 5,373 22 0.41 1,500 -10.02 0.0992
2025-05-06 2025-03-31 13F AMGEN COM 031162100 5,351 -62 -1.15 1,667 18.23 0.1199
2025-01-17 2024-12-31 13F AMGEN COM 031162100 5,413 940 21.01 1,411 -2.15 0.0990
2024-10-24 2024-09-30 13F AMGEN COM 031162100 4,473 -38 -0.84 1,441 2.27 0.1011
2024-08-05 2024-06-30 13F AMGEN COM 031162100 4,511 203 4.71 1,410 15.11 0.1067
2024-04-16 2024-03-31 13F AMGEN COM 031162100 4,308 146 3.51 1,225 2.17 0.0949
2024-02-01 2023-12-31 13F AMGEN COM 031162100 4,162 68 1.66 1,199 8.91 0.0980
2023-10-19 2023-09-30 13F AMGEN COM 031162100 4,094 70 1.74 1,100 23.18 0.0993
2023-07-24 2023-06-30 13F AMGEN COM 031162100 4,024 21 0.52 894 -7.65 0.0807
2023-04-18 2023-03-31 13F AMGEN COM 031162100 4,003 -210 -4.98 968 -12.57 0.0903
2023-01-31 2022-12-31 13F AMGEN COM 031162100 4,213 493 13.25 1,106 31.82 0.1130
2022-11-09 2022-09-30 13F AMGEN COM 031162100 3,720 734 24.58 839 15.56 0.0933
2022-08-11 2022-06-30 13F AMGEN COM 031162100 2,986 -15 -0.50 726 0.00 0.0766
2022-05-05 2022-03-31 13F AMGEN COM 031162100 3,001 3,001 726 0.0682
2022-02-14 2021-12-31 13F AMGEN COM 031162100 0 -2,479 -100.00 0 -100.00
2021-11-12 2021-09-30 13F AMGEN COM 031162100 2,479 678 37.65 527 20.05 0.0534
2021-08-10 2021-06-30 13F AMGEN COM 031162100 1,801 433 31.65 439 29.12 0.0454
2021-05-13 2021-03-31 13F AMGEN COM 031162100 1,368 169 14.10 340 23.19 0.0383
2021-02-09 2020-12-31 13F AMGEN COM 031162100 1,199 0 0.00 276 -9.51 0.0330
2020-11-12 2020-09-30 13F AMGEN COM 031162100 1,199 77 6.86 305 15.09 0.0403
2020-08-11 2020-06-30 13F AMGEN COM 031162100 1,122 0 0.00 265 16.74 0.0370
2020-04-24 2020-03-31 13F AMGEN COM 031162100 1,122 0 0.00 227 -15.93 0.0380
2020-02-07 2019-12-31 13F AMGEN COM 031162100 1,122 0 0.00 270 24.42 0.0411
2019-10-22 2019-09-30 13F AMGEN COM 031162100 1,122 0 0.00 217 4.83 0.0353
2019-08-06 2019-06-30 13F AMGEN COM 031162100 1,122 0 0.00 207 -2.82 0.0342
2019-05-07 2019-03-31 13F AMGEN COM 031162100 1,122 0 0.00 213 -2.29 0.0368
2019-01-25 2018-12-31 13F AMGEN COM 031162100 1,122 0 0.00 218 -6.44 0.0417
2018-10-24 2018-09-30 13F AMGEN COM 031162100 1,122 0 0.00 233 12.56 0.0407
2018-07-20 2018-06-30 13F AMGEN COM 031162100 1,122 -77 -6.42 207 1.47 0.0398
2018-05-10 2018-03-31 13F AMGEN COM 031162100 1,199 0 0.00 204 -1.92 0.0401
2018-02-06 2017-12-31 13F AMGEN COM 031162100 1,199 0 0.00 208 -7.14 0.0386
2017-10-30 2017-09-30 13F AMGEN COM 031162100 1,199 0 0.00 224 8.74 0.0439
2017-07-25 2017-06-30 13F AMGEN COM 031162100 1,199 -450 -27.29 206 -23.99 0.0409
2017-05-02 2017-03-31 13F AMGEN COM 031162100 1,649 573 53.25 271 72.61 0.0568
2017-01-20 2016-12-31 13F AMGEN COM 031162100 1,076 974 954.90 157 823.53 0.0344
2016-11-10 2016-09-30 13F AMGEN COM 031162100 102 -11 -9.73 17 0.00 0.0040
2016-08-11 2016-06-30 13F AMGEN COM 031162100 113 37 48.68 17 54.55 0.0042
2016-05-04 2016-03-31 13F AMGEN COM 031162100 76 1 1.33 11 -8.33 0.0029
2016-02-08 2015-12-31 13F AMGEN COM 031162100 75 0 0.00 12 20.00 0.0032
2015-11-09 2015-09-30 13F AMGEN COM 031162100 75 75 10 0.0026
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.